Loading…
Based on limited metadata, the FDA issued a Warning Letter to Oneness Labs on October 6, 2020, regarding drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the actual compliance issues cited, the complete Warning Letter would need to be reviewed.